149 related articles for article (PubMed ID: 32576716)
1. PRP4 Kinase Domain Loss Nullifies Drug Resistance and Epithelial-Mesenchymal Transition in Human Colorectal Carcinoma Cells.
Ahmed MB; Islam SU; Sonn JK; Lee YS
Mol Cells; 2020 Jul; 43(7):662-670. PubMed ID: 32576716
[TBL] [Abstract][Full Text] [Related]
2. PRP4 kinase induces actin rearrangement and epithelial-mesenchymal transition through modulation of the actin-binding protein cofilin.
Islam SU; Ahmed MB; Lee SJ; Shehzad A; Sonn JK; Kwon OS; Lee YS
Exp Cell Res; 2018 Aug; 369(1):158-165. PubMed ID: 29787735
[TBL] [Abstract][Full Text] [Related]
3. PRP4 Induces Epithelial-Mesenchymal Transition and Drug Resistance in Colon Cancer Cells via Activation of p53.
Islam SU; Ahmed MB; Sonn JK; Jin EJ; Lee YS
Int J Mol Sci; 2022 Mar; 23(6):. PubMed ID: 35328513
[TBL] [Abstract][Full Text] [Related]
4. PRP4 Promotes Skin Cancer by Inhibiting Production of Melanin, Blocking Influx of Extracellular Calcium, and Remodeling Cell Actin Cytoskeleton.
Ahmed MB; Islam SU; Lee YS
Int J Mol Sci; 2021 Jun; 22(13):. PubMed ID: 34209674
[TBL] [Abstract][Full Text] [Related]
5. Curcumin induces radiosensitivity of in vitro and in vivo cancer models by modulating pre-mRNA processing factor 4 (Prp4).
Shehzad A; Park JW; Lee J; Lee YS
Chem Biol Interact; 2013 Nov; 206(2):394-402. PubMed ID: 24144778
[TBL] [Abstract][Full Text] [Related]
6. Curcumin induces apoptosis in human colorectal carcinoma (HCT-15) cells by regulating expression of Prp4 and p53.
Shehzad A; Lee J; Huh TL; Lee YS
Mol Cells; 2013 Jun; 35(6):526-32. PubMed ID: 23686430
[TBL] [Abstract][Full Text] [Related]
7. Functional analysis of the fission yeast Prp4 protein kinase involved in pre-mRNA splicing and isolation of a putative mammalian homologue.
Gross T; Lützelberger M; Weigmann H; Klingenhoff A; Shenoy S; Käufer NF
Nucleic Acids Res; 1997 Mar; 25(5):1028-35. PubMed ID: 9102632
[TBL] [Abstract][Full Text] [Related]
8. The role of hERG1 ion channels in epithelial-mesenchymal transition and the capacity of riluzole to reduce cisplatin resistance in colorectal cancer cells.
Fortunato A
Cell Oncol (Dordr); 2017 Aug; 40(4):367-378. PubMed ID: 28593575
[TBL] [Abstract][Full Text] [Related]
9. Curcumin mediates chemosensitization to 5-fluorouracil through miRNA-induced suppression of epithelial-to-mesenchymal transition in chemoresistant colorectal cancer.
Toden S; Okugawa Y; Jascur T; Wodarz D; Komarova NL; Buhrmann C; Shakibaei M; Boland CR; Goel A
Carcinogenesis; 2015 Mar; 36(3):355-67. PubMed ID: 25653233
[TBL] [Abstract][Full Text] [Related]
10. SGK2 is overexpressed in colon cancer and promotes epithelial-mesenchymal transition in colon cancer cells.
Liu Y; Liu J; Kong X; Li H; Shao J; Jiang Z
Eur J Surg Oncol; 2020 Oct; 46(10 Pt A):1912-1917. PubMed ID: 32565024
[TBL] [Abstract][Full Text] [Related]
11. Antitumor effects of curcumin on the proliferation, migration and apoptosis of human colorectal carcinoma HCT‑116 cells.
Xiang L; He B; Liu Q; Hu D; Liao W; Li R; Peng X; Wang Q; Zhao G
Oncol Rep; 2020 Nov; 44(5):1997-2008. PubMed ID: 33000266
[TBL] [Abstract][Full Text] [Related]
12. Activation of AKT signaling promotes epithelial-mesenchymal transition and tumor growth in colorectal cancer cells.
Suman S; Kurisetty V; Das TP; Vadodkar A; Ramos G; Lakshmanaswamy R; Damodaran C
Mol Carcinog; 2014 Feb; 53 Suppl 1():E151-60. PubMed ID: 24000138
[TBL] [Abstract][Full Text] [Related]
13. An hTERT/ZEB1 complex directly regulates E-cadherin to promote epithelial-to-mesenchymal transition (EMT) in colorectal cancer.
Qin Y; Tang B; Hu CJ; Xiao YF; Xie R; Yong X; Wu YY; Dong H; Yang SM
Oncotarget; 2016 Jan; 7(1):351-61. PubMed ID: 26540342
[TBL] [Abstract][Full Text] [Related]
14. Functional and structural characterization of the prp3 binding domain of the yeast prp4 splicing factor.
Ayadi L; Callebaut I; Saguez C; Villa T; Mornon JP; Banroques J
J Mol Biol; 1998 Dec; 284(3):673-87. PubMed ID: 9826507
[TBL] [Abstract][Full Text] [Related]
15. Human immunodeficiency virus type 2 Gag interacts specifically with PRP4, a serine-threonine kinase, and inhibits phosphorylation of splicing factor SF2.
Bennett EM; Lever AM; Allen JF
J Virol; 2004 Oct; 78(20):11303-12. PubMed ID: 15452250
[TBL] [Abstract][Full Text] [Related]
16. Curcumin reverses irinotecan resistance in colon cancer cell by regulation of epithelial-mesenchymal transition.
Zhang C; Xu Y; Wang H; Li G; Yan H; Fei Z; Xu Y; Li W
Anticancer Drugs; 2018 Apr; 29(4):334-340. PubMed ID: 29420338
[TBL] [Abstract][Full Text] [Related]
17. Nuclear factor I/B promotes colorectal cancer cell proliferation, epithelial-mesenchymal transition and 5-fluorouracil resistance.
Liu Z; Chen J; Yuan W; Ruan H; Shu Y; Ji J; Wu L; Tang Q; Zhou Z; Zhang X; Cheng Y; He S; Shu X
Cancer Sci; 2019 Jan; 110(1):86-98. PubMed ID: 30320939
[TBL] [Abstract][Full Text] [Related]
18. Anticancer effect of a curcumin derivative B63: ROS production and mitochondrial dysfunction.
Zheng A; Li H; Wang X; Feng Z; Xu J; Cao K; Zhou B; Wu J; Liu J
Curr Cancer Drug Targets; 2014; 14(2):156-66. PubMed ID: 24274397
[TBL] [Abstract][Full Text] [Related]
19. microRNA-335 inhibits colorectal cancer HCT116 cells growth and epithelial-mesenchymal transition (EMT) process by targeting Twist1.
Wang J; Wang X; Liu F; Fu Y
Pharmazie; 2017 Aug; 72(8):475-481. PubMed ID: 29441907
[TBL] [Abstract][Full Text] [Related]
20. Mutational analysis of the PRP4 protein of Saccharomyces cerevisiae suggests domain structure and snRNP interactions.
Hu J; Xu Y; Schappert K; Harrington T; Wang A; Braga R; Mogridge J; Friesen JD
Nucleic Acids Res; 1994 May; 22(9):1724-34. PubMed ID: 8202378
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
